Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with rheumatoid arthritis based on the 2010 ACR/EULAR classification criteria
- People who are currently receiving standard-dose rituximab and whose rheumatologist considers them to be responding well to it, and who are being considered for a lower-dose treatment approach
- People taking certain conventional arthritis medications (such as Methotrexate, Leflunomide, Salazopyrine, or Plaquenil) at a dose that has remained unchanged for at least 3 months
- People taking corticosteroids (steroid tablets) at a dose of 10 mg per day or less, with that dose remaining stable for at least 3 months
Who may not be able to join:
- People who are also taking another type of targeted disease-modifying therapy alongside rituximab
- People who have Sjögren's syndrome or another inflammatory joint or autoimmune condition in addition to rheumatoid arthritis
- People who have fibromyalgia or another condition that could affect how disease activity is measured
- People who have an active blood or lymph system disease affecting a type of white blood cell called lymphocytes (such as chronic lymphocytic leukaemia, Hodgkin's lymphoma, non-Hodgkin's lymphoma, or certain other lymphoma types)
- People who do not agree to their personal data being used for research purposes
- People who fall under specific protected legal categories under French public health law, such as minors or adults under legal protection (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 247475917
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Observed Disease Activity Score(DAS) 28-CRP; Calculated DAS28-CRP
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.